What is ToeFIX's primary focus?

ToeFIX develops simple, effective medical devices for treating prevalent foot problems, particularly for high-risk patients who cannot undergo foot surgery.

What type of patients does ToeFIX's technology target?

ToeFIX's technology is designed for high-risk patients such as diabetics, seniors, and individuals with blood-flow problems.

What is the core functionality of the ToeFIX device?

The ToeFIX device elevates the nail edge to extract ingrown toenails from the groove, staying glued for three days to change the nail's growth pattern to a normal, non-pathological state.

When was ToeFIX founded?

ToeFIX was founded in January 2008.

What is the current status of ToeFIX?

ToeFIX is currently inactive, as of November 2016.

What is the total amount of funding ToeFIX has raised?

ToeFIX has raised a total of $500,000 across two funding rounds.

When was ToeFIX's last funding round?

ToeFIX's last funding round occurred in May 2015, raising $300,000.

Who is a key founder of ToeFIX?

Aharon Liberson is the Chairman and Co-Founder of ToeFIX.

ToeFIX

Medical Devices for Treating Foot Conditions

Non Active, Nov 2016

Mature Haifa, Israel Founded 2008

Last updated 2026-06-18

Raised $300k funding round, May 2015
Raised $200k funding round, Jul 2014

Total raised

$500K

Last: 2015-05

Stage

Mature

Founded

2008

Headcount

Haifa, Israel

Sector

—

About

ToeFIX develops simple, effective medical devices that address the source of prevalent foot problems. The company's technology is meant for high-risk patients who can't undergo foot surgery, such as diabetics, seniors, and people who suffer from blood-flow problems. All of ToeFIX's products are safe and easy to use. The ToeFIX device causes nail edge elevation, extracting ingrown toenailsfrom the groove. The device stays glued on for three days. During that period, the device changes the nail's growth to a normal, non-pathological, non-ingrown pattern.

Funding history · 2 rounds · $500K total

2015-05

$300K

2014-07

$200K

Q&A

What is ToeFIX's primary focus?: ToeFIX develops simple, effective medical devices for treating prevalent foot problems, particularly for high-risk patients who cannot undergo foot surgery.
What type of patients does ToeFIX's technology target?: ToeFIX's technology is designed for high-risk patients such as diabetics, seniors, and individuals with blood-flow problems.
What is the core functionality of the ToeFIX device?: The ToeFIX device elevates the nail edge to extract ingrown toenails from the groove, staying glued for three days to change the nail's growth pattern to a normal, non-pathological state.
When was ToeFIX founded?: ToeFIX was founded in January 2008.
What is the current status of ToeFIX?: ToeFIX is currently inactive, as of November 2016.
What is the total amount of funding ToeFIX has raised?: ToeFIX has raised a total of $500,000 across two funding rounds.
When was ToeFIX's last funding round?: ToeFIX's last funding round occurred in May 2015, raising $300,000.
Who is a key founder of ToeFIX?: Aharon Liberson is the Chairman and Co-Founder of ToeFIX.

Team · 1

Aharon Liberson

Founder · Chairman & Co-Founder

LinkedIn ↗

Sectors & technology

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

ConsumersDemographics & FamilySeniorsHealthcare & Life SciencesHealthcareProvidersPatients

Business model

B2B2C

Highlights

1 Patents

External links

LinkedIn	linkedin.com/company/1603653
Facebook	facebook.com/Toefix?ref=br_tf
YouTube	youtube.com/user/toefix

Identifiers & details

Founded	2008-1
Employees (exact)	2
Status reason	Non Active, Nov 2016